Skip to content

Drug interactions

Insulin glargine-lixisenatide + Methylprednisolone

Severity: Moderate

Insulin glargine-lixisenatide and Methylprednisolone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Systemic methylprednisolone raises blood glucose and can substantially reduce the effectiveness of insulin and GLP-1 therapy. Higher doses and longer courses carry greater risk of significant hyperglycemia.

What this interaction means in plain words

Insulin glargine-lixisenatide and Methylprednisolone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Insulin glargine-lixisenatide belongs to Endocrine; Methylprednisolone belongs to Endocrine.

Evidence level: High

Why it happens

Glucocorticoids increase hepatic gluconeogenesis and peripheral insulin resistance, opposing glucose lowering.

What to do

Monitor blood glucose closely during methylprednisolone therapy and increase the insulin dose as needed. Reduce it again as the steroid is tapered to avoid hypoglycemia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine-lixisenatide and Methylprednisolone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Insulin glargine-lixisenatide with Methylprednisolone?

MediHelp rates the interaction as moderate. Insulin glargine-lixisenatide and Methylprednisolone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Systemic methylprednisolone raises blood glucose and can substantially reduce the effectiveness of insulin and GLP-1 therapy. Higher doses and longer courses carry greater risk of significant hyperglycemia.

How serious is the interaction between Insulin glargine-lixisenatide and Methylprednisolone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely during methylprednisolone therapy and increase the insulin dose as needed. Reduce it again as the steroid is tapered to avoid hypoglycemia.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in